Quick Answer
CytoDyn Inc. reported Total Assets of $18.05 million for the year ending 2025.
- CytoDyn Inc. showed an increase of +62.1% in Total Assets from 2024 to 2025.
- This data is from CytoDyn Inc.'s annual report (Form 10-K), filed with the SEC on July 25, 2025.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2011: $981.1 thousand | Q1 2012: $2.56 million | Q4 2012: $5.56 million | Q1 2013: $4.48 million | Q3 2013: $4.45 million | Q4 2013: $13.64 million | Q1 2014: $11.02 million | Q3 2014: $5.59 million | Q4 2014: $5.66 million | Q1 2015: $4.67 million | Q3 2015: $6.14 million | Q4 2015: $6.56 million | Q1 2016: $14.59 million | Q3 2016: $9.29 million | Q4 2016: $15.67 million | Q1 2017: $14.76 million | Q3 2017: $6.13 million | Q4 2017: $6.49 million | Q1 2018: $8.28 million | Q3 2018: $9.03 million | Q4 2018: $20.39 million | Q1 2019: $20.43 million | Q3 2019: $18.39 million | Q4 2019: $17.92 million | Q1 2020: $38.82 million | Q3 2020: $93.36 million | Q4 2020: $143.76 million | Q1 2021: $113.65 million | Q3 2021: $104.97 million | Q4 2021: $103.70 million | Q1 2022: $94.08 million | Q3 2022: $28.39 million | Q4 2022: $7.07 million | Q1 2023: $14.64 million | Q3 2023: $12.41 million | Q4 2023: $9.24 million | Q1 2024: $10.27 million | Q3 2024: $28.02 million | Q4 2024: $24.88 million | Q1 2025: $21.19 million | Q2 2025: $18.05 million | Q3 2025: $13.48 million | Q4 2025: $8.94 million.
- Over the full 15 years of available data (2011 to 2025), CytoDyn Inc.'s Total Assets has grown by 804.8%.
- Historical annual values: Fiscal year 2025: $18.05 million | Fiscal year 2024: $11.14 million | Fiscal year 2023: $11.29 million | Fiscal year 2022: $29.19 million | Fiscal year 2021: $132.08 million | Fiscal year 2020: $50.51 million | Fiscal year 2019: $20.87 million | Fiscal year 2018: $4.90 million | Fiscal year 2017: $8.06 million | Fiscal year 2016: $13.79 million | Fiscal year 2015: $4.68 million | Fiscal year 2014: $8.43 million | Fiscal year 2013: $4.16 million | Fiscal year 2012: $1.07 million | Fiscal year 2011: $1.99 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: